NDC properties for "testosterone 1 % Transdermal Gel, 2.5 GM" (RxCUI 1597123)
About this data
The tables show NDC propoerties for testosterone 1 % Transdermal Gel, 2.5 GM with the RxCUI 1597123
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone 1 % Transdermal Gel, 2.5 GM (RxCUI 1597123)
| ANDA | ANDA076737 |
|---|---|
| ANDA | ANDA076744 |
| ANDA | ANDA212984 |
| MMSL_CODE | BD22846 |
| MMSL_CODE | CD12426 |
| MMSL_CODE | CD22846 |
| RxCUI | 1597123 |
| SPL_SET_ID | 5834d34f-839d-412c-b74c-da1dad2cfa88 |
| SPL_SET_ID | 7d655d6d-01da-488c-bd4e-c7fbe0ace38c |
| SPL_SET_ID | ee54c393-bcfe-4a52-b7b3-1da8750f35d9 |
| VUID | 4014743 |
| VUID | 4034717 |
| VUID | 4034721 |
| Prescribable Synonym | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel |
| RXNAV_STR | 2500 MG testosterone 0.01 MG/MG Topical Gel |
| RxNorm Name | 2500 MG testosterone 0.01 MG/MG Topical Gel |
| RxNorm Synonym | testosterone 1 % Transdermal Gel, 2.5 GM |
| Related queries | Interactions (for RxCUI 1597123) |
NDC Properties
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 00591321617
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-17 |
| NDC Item | 00591321617 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 00591321630
| NDC 9 | 0591-3216 |
|---|---|
| NDC 10 | 0591-3216-30 |
| NDC Item | 00591321630 |
| Packaging | 30 PACKET in 1 CARTON (0591-3216-30) / 2.5 g in 1 PACKET (0591-3216-17) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3216 |
NDC Item 21922001952
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-52 |
| NDC Item | 21922001952 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-52) / 25 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 855168 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884041848
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-48 |
| NDC Item | 49884041848 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 49884041872
| NDC 9 | 49884-418 |
|---|---|
| NDC 10 | 49884-418-72 |
| NDC Item | 49884041872 |
| Packaging | 30 PACKET in 1 CARTON (49884-418-72) / 2.5 g in 1 PACKET (49884-418-48) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-418 |
NDC Item 63629212401
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-1 |
| NDC Item | 63629212401 |
| Packaging | 30 PACKET in 1 CARTON (63629-2124-1) / 2.5 g in 1 PACKET (63629-2124-2) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 63629212402
| NDC 9 | 63629-2124 |
|---|---|
| NDC 10 | 63629-2124-2 |
| NDC Item | 63629212402 |
| Packaging | 2.5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 657851 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-2124 |
NDC Item 64380015101
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-01 |
| NDC Item | 64380015101 |
| Packaging | 2.5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |
NDC Item 64380015102
| NDC 9 | 64380-151 |
|---|---|
| NDC 10 | 64380-151-02 |
| NDC Item | 64380015102 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-151-02) / 2.5 g in 1 DOSE PACK (64380-151-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear,colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-151 |